Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.6K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Genetic Lingo01:11

Genetic Lingo

113.3K
Overview
113.3K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Lethal Alleles02:41

Lethal Alleles

17.6K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
17.6K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

876
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
876

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genotype-Phenotype Correlations for ATX-TBP (SCA17): MDSGene Systematic Review.

Movement disorders : official journal of the Movement Disorder Society·2022
Same author

DJ-1 regulates mitochondrial gene expression during ischemia and reperfusion.

Free radical biology & medicine·2022
Same author

Let's make science, not war!

Science advances·2022
Same author

Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review.

Dystonia (Lausanne, Switzerland)·2022
Same author

Familial Cerebellar Ataxia and Amyotrophic Lateral Sclerosis/Frontotemporal Dementia with DAB1 and C9ORF72 Repeat Expansions: An 18-Year Study.

Movement disorders : official journal of the Movement Disorder Society·2022
Same author

What if I could become the doctor I always wanted to be?

European journal of neurology·2022

Related Experiment Video

Updated: Dec 29, 2025

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

2.9K

The Wilson films--Huntington's chorea.

Christine Klein1

  • 1Section of Clinical and Molecular Neurogenetics, Department of Neurology, University of Luebeck, Luebeck, Germany. christine.klein@neuro.uni-luebeck.de

Movement Disorders : Official Journal of the Movement Disorder Society
|December 16, 2011
PubMed
Summary

This case study discusses Huntington's disease (HD) in a 68-year-old man, highlighting genetic factors like trinucleotide repeats and reduced penetrance. Current diagnostic tests are advanced, but effective HD treatments remain elusive.

More Related Videos

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

10.0K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

11.0K

Related Experiment Videos

Last Updated: Dec 29, 2025

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

2.9K
Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

10.0K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

11.0K

Area of Science:

  • Neurology
  • Genetics
  • Neurodegenerative Disorders

Background:

  • Presents a case of Huntington's disease (HD) in a 68-year-old male with chorea, impaired fixation, and cognitive decline.
  • Discusses atypical presentation of HD with late onset and negative family history, suggesting genetic factors like expanded trinucleotide repeats in the HTT gene and reduced penetrance.

Purpose of the Study:

  • To analyze a clinical case of Huntington's disease (HD) with unusual genetic and presentation characteristics.
  • To review the historical development and current status of diagnostic genetic testing for HD.
  • To highlight the unmet need for effective cause-directed therapies for HD.

Main Methods:

  • Clinical case presentation and analysis.
  • Review of genetic testing principles for Huntington's disease (HD).
  • Discussion of the current therapeutic landscape for HD.

Main Results:

  • The patient's presentation is consistent with Huntington's disease (HD), influenced by specific genetic repeat lengths and reduced penetrance.
  • Highly sensitive and specific genetic tests for HD have been available for nearly two decades, guiding various testing strategies.
  • Despite diagnostic advancements, effective treatments targeting the cause of HD are still under development.

Conclusions:

  • Genetic testing has revolutionized Huntington's disease (HD) diagnosis, enabling symptomatic, presymptomatic, and prenatal testing.
  • The case underscores the complexity of HD genetics, including late onset and reduced penetrance.
  • There is a critical need for the translation of research into effective therapies to combat Huntington's disease (HD).